Literature DB >> 2002274

Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).

W C Nichols1, J J Liepnieks, E L Snyder, M D Benson.   

Abstract

Senile cardiac amyloidosis, also known as senile systemic amyloidosis, is a sporadic disease of late onset but with increasing incidence with age. Recently it has been shown in one case that amyloid deposits contained a transthyretin variant with an isoleucine for valine substitution at position 122. A second case with the transthyretin isoleucine 122 variant is reported here. This individual, who died with restrictive cardiomyopathy, was found to be homozygous for this transthyretin variant and his son heterozygous for the variant. A brother of the propositus was also homozygous for the variant but died of a cerebral vascular accident without being evaluated for amyloidosis. These studies show genetic transmission of the isoleucine-122 transthyretin variant associated with this form of cardiac amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002274

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Homozygous transthyretin mutation in an African American Male.

Authors:  Eapen K Jacob; William D Edwards; Mark Zucker; Cyril D'Cruz; Surya V Seshan; Frank W Crow; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.

Authors:  D R Jacobson
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

3.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Authors:  D R Jacobson; M Ittmann; J N Buxbaum; R Wieczorek; P D Gorevic
Journal:  Tex Heart Inst J       Date:  1997

Review 4.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

5.  Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.

Authors:  T D O'Brien; P C Butler; D K Kreutter; L A Kane; N L Eberhardt
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

6.  Structure of Met30 variant of transthyretin and its amyloidogenic implications.

Authors:  C J Terry; A M Damas; P Oliveira; M J Saraiva; I L Alves; P P Costa; P M Matias; Y Sakaki; C C Blake
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

7.  The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.

Authors:  Daniel R Jacobson; Alice A Alexander; Clement Tagoe; W T Garvey; Scott M Williams; Sara Tishkoff; David Modiano; Sodiomon B Sirima; Issa Kalidi; Amadou Toure; Joel N Buxbaum
Journal:  Mol Genet Genomic Med       Date:  2016-07-14       Impact factor: 2.183

8.  Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.

Authors:  Margaret M Parker; Scott M Damrauer; Catherine Tcheandjieu; David Erbe; Emre Aldinc; Philip N Hawkins; Julian D Gillmore; Leland E Hull; Julie A Lynch; Jacob Joseph; Simina Ticau; Alexander O Flynn-Carroll; Aimee M Deaton; Lucas D Ward; Themistocles L Assimes; Philip S Tsao; Kyong-Mi Chang; Daniel J Rader; Kevin Fitzgerald; Akshay K Vaishnaw; Gregory Hinkle; Paul Nioi
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.